(2003; 148 pages)
The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 22 to 26 October 2001. The meeting was opened on behalf of the Director-General by Dr Y. Suzuki, Executive Director, Health Technology and Pharmaceuticals, who said that, since the last meeting of the Committee, there has been more evidence of globalization and the harmonization of specifications for pharmaceutical preparations, especially for pharmaceuticals used in the treatment of HIV, tuberculosis and malaria. WHO was committed to helping to ensure the quality of pharmaceuticals and to treat these diseases.
Dr J.D. Quick, Director, Essential Drugs and Medicines Policy, briefed the Committee on the WHO strategy for medicines, which focuses on:
- ready access to essential medicines at affordable prices;
- quality and safety of such medicines;
- rational drug use;
- effective national drug policies.
It was intended that the information arising from the meeting would be readily available through the WHO web site and through the “Global Medicines Family”.
Dr L. Rägo, Coordinator, Quality Assurance and Safety: Medicines (QSM), informed the Committee about the wide range of activities undertaken by the QSM team. A substantial number of countries were now using the WHO good manufacturing practices (GMP) guide and there was greater cooperation with WHO collaborating centres.